银诺医药-B(02591)公布，于2025年12月1日，公司及银诺技术(公司一间直接全资附属公司)以代价合共 人民币1.25亿元(即其总本金额)分别向宁波银行认购一款结构性存款产品(即宁波银行结构性存款产 品)。 ...

Core Viewpoint - Silver诺医药-B (02591.HK) announced the subscription of a structured deposit product from Ningbo Bank for a total consideration of RMB 125 million, which represents the total principal amount [1] Group 1 - The company, along with its wholly-owned subsidiary Silver诺技术, will subscribe to the structured deposit product [1] - The total investment amount for the structured deposit product is RMB 125 million [1]

银诺医药-B(02591)公布，于2025年12月1日，公司及银诺技术(公司一间直接全资附属公司)以代价合共 人民币1.25亿元(即其总本金额)分别向宁波银行认购一款结构性存款产品(即宁波银行结构性存款产 品)。 ...

Core Viewpoint - Silver诺医药-B (02591.HK) announced the subscription of a structured deposit product from Ningbo Bank for a total consideration of RMB 105 million, which is equivalent to its total principal amount [1] Group 1 - The company, along with its wholly-owned subsidiary Silver诺技术, will invest in the structured deposit product [1] - The total investment amount is RMB 105 million, indicating a significant financial commitment by the company [1]

Core Viewpoint - Silver诺医药-B (02591) announced the subscription of a structured deposit product from Ningbo Bank for a total consideration of RMB 105 million, which is equivalent to its total principal amount [1] Group 1 - The company, along with its wholly-owned subsidiary Silver诺技术, will invest in the structured deposit product [1] - The transaction is set to take place on November 3, 2025 [1]

Group 1 - The company announced that on August 18, 2025, its wholly-owned subsidiary, Yinnuo Technology, subscribed to a structured deposit product from China Merchants Bank for a total amount of RMB 30 million, which is the principal amount [1] - On September 1, 2025, the company and Yinnuo Technology together subscribed to a structured deposit product from Ningbo Bank for a total amount of RMB 105 million, which is the total principal amount [1]